Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Focusing on short term investment goals can yield quick financial returns. Discover the right timing for your investment strategy.
27,474 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As of July 8, 2026, investors are weighing how a $300,000 portfolio can yield steady monthly income. Three clear path...
The market debate is alive: should you buy the beaten-down growth story of Celsius or spread risk with Coca-Cola and ...
The U.S. Treasury must refinance about $8 trillion in debt over the next year, a record load that market watchers say...
A growing share of Americans rely on pensions to anchor retirement. This piece breaks down how a $2,000 monthly pensi...
Cava Group stunned investors with a standout first-quarter performance, sending the stock higher. But a quick rally d...
SpaceX's blockbuster IPO drew record demand and about $75 billion in funding, but tokenized pre-offers fell short for...
New research shows AI projects struggle to deliver ROI unless companies redesign roles, workflows, and incentives. Ex...
Progressive Insurance fell today as markets weighed mixed quarterly results. This article breaks down the numbers, ex...
A major fund stepped in with a bold $30 million wager on Floor & Decor after a sharp 30% decline. This article breaks...
Discover the quiet power of Baupost. This article unpacks Seth Klarman’s patient, risk-aware value approach, how the ...
Sleep Number's 2025 earnings story centers on demand shifts, pricing discipline, and inventory health. This guide bre...